Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;75(3):742-744.
doi: 10.1016/j.jhep.2021.05.027. Epub 2021 Jun 6.

Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19"

Ze-Yang Ding  1 , Gan-Xun Li  1 , Chang Shu  1 , Ping Yin  2 , Bixiang Zhang  3 ; Tongji multidisciplinary Team for Treating COVID-19 (TTTC)
Affiliations
Comment

Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19"

Ze-Yang Ding et al. J Hepatol. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interests All authors declare no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
Discriminative ability and clinical usefulness of the predict model for in-hospital mortality of COVID-19. (A) AUROC for the proposed nomogram and the simplified version. (B) Decision curve analysis for the nomogram and simplified risk prediction models. (This figure appears in color on the web.)
See this image and copyright information in PMC

Comment on

  • Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
    Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Ding ZY, et al. J Hepatol. 2021 Jun;74(6):1295-1302. doi: 10.1016/j.jhep.2020.12.012. Epub 2020 Dec 19. J Hepatol. 2021. PMID: 33347952 Free PMC article.

References

    1. Ding Z.Y., Li G.X., Chen L., Shu C., Song J., Wang W., et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021;74:1295–1302. - PMC - PubMed
    1. Fu Y., Zhu R., Bai T., Han P., He Q., Jing M., et al. Clinical features of patients infected with coronavirus disease 2019 with elevated liver biochemistries: a multicenter, retrospective study. Hepatology. 2021;73:1509–1520. - PMC - PubMed
    1. Iavarone M., D'Ambrosio R., Soria A., Triolo M., Pugliese N., Del Poggio P., et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020;73:1063–1071. - PMC - PubMed
    1. Marjot T., Webb G.J., Barritt ASt, Moon A.M., Stamataki Z., Wong V.W., et al. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021;18:348–364. - PMC - PubMed
    1. Asselah T., Durantel D., Pasmant E., Lau G., Schinazi R.F. COVID-19: discovery, diagnostics and drug development. J Hepatol. 2021;74:168–184. - PMC - PubMed